Back

The effect of underweight on mid-term outcome following transcatheter aortic valve implantation: an insight from multicenter registry

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Valvular Heart Disease ePosters Intervention ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Taiyo Tezuka

Sakakibara Heart Institute, Tokyo (Japan)

132 More presentations in this session

Presentation thumbnail
Left atrial dynamics in the hemodynamic response during exercise in patients with asymptomatic severe aortic stenosis: a cardiopulmonary imaging study
Doctor T. Sugimoto (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Preserved Th2 lymphocytes improve prognosis of diabetic patients undergoing TAVR
Doctor J. Hoffmann (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
Platelet membrane-coated nanoparticles target sclerotic aortic valves in ApoE-/- mice by multiple binding mechanisms under pathological shear stress
Doctor H. Yang (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Long telomere length in circulating leukocytes is associated with monocytosis and poorer survival in patients with transcatheter aortic valve replacement
Doctor J. Hoffmann (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
Longitudinal strain in patients with severe aortic regurgitation: superiority to ejection fraction for detection of myocardial dysfunction
Doctor J. Reil (Luebeck, DE)
Abstract Slides

Access the full session

Session thumbnail
Valvular Heart Disease ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
The effect of body mass index on all-cause mortality in patients undergoing cardiac resynchronization therapy
22 May 2023
thumbnail
Congress Presentation
1 September 2019
thumbnail
Congress Presentation
Predictors of permanent pacemaker and long-term clinical impact on survival after Transcatheter Aortic Valve Replacement
29 June 2021
thumbnail
Congress Presentation
Malnutrition is a major factor to affect prognosis of patients undergo percutaneous coronary intervention for coronary artery disease with calcified lesions
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources